KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Net Cash Flow (2016 - 2025)

Bausch Health Companies' Net Cash Flow history spans 17 years, with the latest figure at -$22.0 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 104.53% year-over-year to -$22.0 million; the TTM value through Dec 2025 reached $63.0 million, down 77.09%, while the annual FY2025 figure was $63.0 million, 77.09% down from the prior year.
  • Net Cash Flow for Q4 2025 was -$22.0 million at Bausch Health Companies, up from -$397.0 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $547.0 million in Q2 2025 and bottomed at -$1.4 billion in Q3 2022.
  • The 5-year median for Net Cash Flow is $25.5 million (2021), against an average of -$24.2 million.
  • The largest annual shift saw Net Cash Flow crashed 26940.0% in 2022 before it surged 544.72% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at $219.0 million in 2021, then crashed by 71.23% to $63.0 million in 2022, then soared by 158.73% to $163.0 million in 2023, then soared by 198.16% to $486.0 million in 2024, then tumbled by 104.53% to -$22.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Net Cash Flow are -$22.0 million (Q4 2025), -$397.0 million (Q3 2025), and $547.0 million (Q2 2025).